Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,587 | 44,909 | 19,672 | N/A | 510 |
| Marketable Securities | 70,113 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 5 | 9 |
| TOTAL | $103,977 | $44,975 | $19,846 | $7 | $524 |
| Non-Current Assets | |||||
| PPE Net | 1,676 | 1,532 | 28 | 22 | 28 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 16 |
| TOTAL | $1,676 | $1,532 | $28 | $22 | $44 |
| Total Assets | $105,653 | $46,507 | $19,874 | $29 | $568 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 958 | 1,248 | 413 | 1,098 | 190 |
| Accrued Expenses | 672 | 414 | 1,857 | 3,769 | 222 |
| Other current liabilities | N/A | N/A | N/A | N/A | 7,938 |
| TOTAL | $1,630 | $1,662 | $2,270 | $11,349 | $13,349 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,630 | $1,662 | $2,270 | $11,349 | $13,349 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,568 | 44,082 | 22,059 | 15,094 | 783 |
| Common Shares | 2 | 247 | 246 | 245 | 3 |
| Retained earnings | -104,222 | -76,562 | -64,527 | -30,684 | -27,377 |
| Other shareholders' equity | 48 | 0 | 0 | 0 | 0 |
| TOTAL | $104,023 | $44,845 | $17,604 | $-11,320 | $-12,781 |
| Total Liabilities And Equity | $105,653 | $46,507 | $19,874 | $29 | $569 |